Ryan P. Werntz

发表

Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection

S. Eggener, Ryan P. Werntz, S. Pearce, 2018, Current opinion in urology.

Novel focal therapy treatment options for prostate cancer

S. Eggener, Ryan P. Werntz, 2017, Current opinion in urology.

Re: Use of Active Surveillance or Watchful Waiting for Low-risk Prostate Cancer and Management Trends Across Risk Groups in the United States 2010-2015.

S. Eggener, Ryan P. Werntz, 2019, European urology.

Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage

G. Steinberg, V. Packiam, Ryan P. Werntz, 2019, Current Urology Reports.

Cystectomy in the female patient

T. Koppie, A. Stenzl, G. Gakis, 2015 .

PD44-02 TRENDS IN PSA UTILIZATION BY PRIMARY CARE PHYSICIANS: IMPACT OF THE USPSTF RECOMMENDATION

C. Amling, M. Conlin, Ryan P. Werntz, 2015 .

A Simple Neobladder Using a Porcine Model: The Double Limb U-Pouch.

C. Amling, J. Barry, Akash A. Kapadia, 2017, Urology.

Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.

S. Eggener, Ryan P. Werntz, Christopher B Riedinger, 2018, Urology.

A rare case of pancreatic adenocarcinoma metastasized to the bladder

C. Marguet, Ryan P. Werntz, William F. Abel, 2020, Urology case reports.

Transurethral resection and surveillance of a well-differentiated neuroendocrine tumor in a ileal neobladder

G. Paner, Audry Kang, Ryan P. Werntz, 2020, Urology case reports.

Bilateral Nerve-Sparing Robot-Assisted Retroperitoneal Lymph Node Dissection: A Minimally Invasive Approach.

Ryan P. Werntz, C. Colwell, Johnny R Lindquist, 2022, Journal of endourology.

The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy.

N. Smith, G. Steinberg, V. Packiam, 2020, European urology focus.

The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data

N. Smith, R. Matulewicz, Joseph F Rodriguez, 2018, Prostate Cancer and Prostatic Diseases.

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

S. Eggener, G. Steinberg, W. Stadler, 2019, Journal of Immunotherapy for Cancer.

Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source.

C. Amling, T. Koppie, Kamran P Sajadi, 2018, Urologic oncology.

The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.

N. Smith, G. Steinberg, V. Packiam, 2018, Urologic oncology.

National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy.

S. Eggener, V. Packiam, Ryan P. Werntz, 2020, Urologic oncology.

Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.

C. Dinney, M. Milowsky, D. Bajorin, 2019, JAMA oncology.

Defining risk of micrometastatic disease and tumor recurrence in patients with stage I testicular germ cell tumors.

S. Eggener, Ryan P. Werntz, 2020, Translational andrology and urology.

Association of the commensal urinary microbiome with response to Bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer.

G. Steinberg, R. Sweis, J. Bloodworth, 2019, Journal of Clinical Oncology.

Testicular Cancer: Epidemiology, Diagnosis, and Management.

S. Eggener, Ryan P. Werntz, Z. Smith, 2018, The Medical clinics of North America.

Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)

G. Steinberg, Ryan P. Werntz, B. Adamic, 2018, World Journal of Urology.

Optical Techniques for Bladder Cancer Detection: The Role of Cystoscopy and Enhanced Cystoscopy

V. Packiam, Ryan P. Werntz, Keiko A. L. Cooley, 2021, Comprehensive Diagnostic Approach to Bladder Cancer.

The Impact of Omission of Intraoperative Frozen Section Prior to Orthotopic Neobladder Reconstruction.

G. Steinberg, Ryan P. Werntz, B. Adamic, 2019, The Journal of urology.

The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis.

J. Cheville, S. Boorjian, I. Frank, 2021, Urologic oncology.

Outcomes of patients with high-risk non-muscle invasive bladder cancer (NMIBC) who undergo radical cystectomy after BCG and subsequent salvage intravesical therapy.

J. Cheville, S. Boorjian, I. Frank, 2020 .

Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions.

A. Zietman, G. Steinberg, J. Aragon-Ching, 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

The impact of surgical duration on complications after transurethral resection of the prostate: an analysis of NSQIP data

N. Smith, R. Matulewicz, R. Fantus, 2018, Prostate Cancer and Prostatic Diseases.

Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)

G. Steinberg, Ryan P. Werntz, B. Adamic, 2018, World Journal of Urology.

Testicular Cancer: Epidemiology, Diagnosis, and Management.

S. Eggener, Ryan P. Werntz, Z. Smith, 2018, The Medical clinics of North America.